RPRX
Repros Therapeutics Inc.
RPRX
RPRX
Delisted
RPRX was delisted on the 31st of January, 2018.
29 hedge funds and large institutions have $2.51M invested in Repros Therapeutics Inc. in 2017 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 13 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
less capital invested
Capital invested by funds: $ → $
77% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 13
Holders
29
Holding in Top 10
–
Calls
$223K
Puts
$3K
Top Buyers
| 1 | +$105K | |
| 2 | +$44K | |
| 3 | +$15K | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$4.73K |
Top Sellers
| 1 | -$935K | |
| 2 | -$137K | |
| 3 | -$45K | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$44K |
| 5 |
BlackRock
New York
|
-$39.6K |